Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $88,414 | 37 | 71.9% |
| Food and Beverage | $14,526 | 780 | 11.8% |
| Travel and Lodging | $12,190 | 25 | 9.9% |
| Consulting Fee | $5,828 | 1 | 4.7% |
| Gift | $1,430 | 1 | 1.2% |
| Education | $541.18 | 20 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $82,311 | 237 | $0 (2023) |
| Genentech USA, Inc. | $17,915 | 96 | $0 (2023) |
| Mallinckrodt Enterprises LLC | $13,621 | 33 | $0 (2019) |
| Teva Pharmaceuticals USA, Inc. | $3,811 | 181 | $0 (2023) |
| EMD Serono, Inc. | $958.15 | 57 | $0 (2023) |
| GENZYME CORPORATION | $785.70 | 42 | $0 (2023) |
| Biogen, Inc. | $595.58 | 47 | $0 (2023) |
| Mallinckrodt Hospital Products Inc. | $405.94 | 23 | $0 (2023) |
| Amneal Pharmaceuticals LLC | $376.30 | 23 | $0 (2023) |
| ABBVIE INC. | $317.31 | 20 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $2,332 | 122 | Teva Pharmaceuticals USA, Inc. ($441.21) |
| 2022 | $2,055 | 138 | Teva Pharmaceuticals USA, Inc. ($627.82) |
| 2021 | $2,133 | 125 | Novartis Pharmaceuticals Corporation ($626.60) |
| 2020 | $1,362 | 88 | Teva Pharmaceuticals USA, Inc. ($451.27) |
| 2019 | $12,438 | 149 | Novartis Pharmaceuticals Corporation ($10,649) |
| 2018 | $35,033 | 117 | Genentech USA, Inc. ($17,148) |
| 2017 | $67,577 | 125 | Novartis Pharmaceuticals Corporation ($57,877) |
All Payment Transactions
864 individual payment records from CMS Open Payments — Page 1 of 35
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/21/2023 | Neurelis, Inc. | VALTOCO (Drug) | Food and Beverage | In-kind items and services | $15.11 | General |
| Category: EPILEPSY | ||||||
| 12/12/2023 | EMD Serono, Inc. | MAVENCLAD (Drug) | Food and Beverage | Cash or cash equivalent | $21.38 | General |
| Category: Neurology | ||||||
| 12/12/2023 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $11.03 | General |
| Category: Neurology | ||||||
| 12/09/2023 | GENZYME CORPORATION | — | Food and Beverage | In-kind items and services | $21.92 | General |
| 12/06/2023 | Biogen, Inc. | TYSABRI (Biological), VUMERITY | Food and Beverage | In-kind items and services | $21.63 | General |
| Category: Neurology | ||||||
| 12/05/2023 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $18.71 | General |
| Category: Neurology | ||||||
| 11/21/2023 | Axsome Therapeutics, Inc. | Sunosi (Drug) | Food and Beverage | In-kind items and services | $24.04 | General |
| Category: Neurology | ||||||
| 11/20/2023 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $25.52 | General |
| Category: PAIN | ||||||
| 11/15/2023 | Genentech USA, Inc. | Ocrevus (Biological) | Food and Beverage | In-kind items and services | $14.82 | General |
| Category: Immunology | ||||||
| 11/15/2023 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $3.17 | General |
| Category: Neurology | ||||||
| 11/14/2023 | EMD Serono, Inc. | MAVENCLAD (Drug) | Food and Beverage | Cash or cash equivalent | $20.10 | General |
| Category: Neurology | ||||||
| 11/08/2023 | Amneal Pharmaceuticals LLC | RYTARY (Drug) | Food and Beverage | In-kind items and services | $23.71 | General |
| Category: NEUROLOGY | ||||||
| 11/02/2023 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $30.48 | General |
| Category: Central Nervous System | ||||||
| 11/02/2023 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $17.89 | General |
| Category: Neuroscience | ||||||
| 11/01/2023 | Biogen, Inc. | TYSABRI (Biological), VUMERITY | Food and Beverage | In-kind items and services | $22.33 | General |
| Category: Neurology | ||||||
| 11/01/2023 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $9.00 | General |
| Category: Neurology | ||||||
| 11/01/2023 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $2.25 | General |
| Category: Neurology | ||||||
| 10/31/2023 | Neurelis, Inc. | VALTOCO (Drug) | Food and Beverage | In-kind items and services | $16.74 | General |
| Category: EPILEPSY | ||||||
| 10/25/2023 | Genentech USA, Inc. | Ocrevus (Biological) | Food and Beverage | In-kind items and services | $14.52 | General |
| Category: Immunology | ||||||
| 10/24/2023 | EMD Serono, Inc. | MAVENCLAD (Drug) | Food and Beverage | Cash or cash equivalent | $18.66 | General |
| Category: Neurology | ||||||
| 10/23/2023 | TG Therapeutics, Inc. | BRIUMVI (Drug) | Food and Beverage | In-kind items and services | $20.31 | General |
| Category: Immunology | ||||||
| 10/17/2023 | GENZYME CORPORATION | — | Food and Beverage | In-kind items and services | $26.29 | General |
| 10/12/2023 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $26.08 | General |
| Category: Central Nervous System | ||||||
| 10/11/2023 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $27.40 | General |
| Category: Neurology | ||||||
| 10/10/2023 | Amneal Pharmaceuticals LLC | RYTARY (Drug) | Food and Beverage | In-kind items and services | $22.20 | General |
| Category: NEUROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 188 | 244 | $104,058 | $21,963 |
| 2022 | 3 | 118 | 229 | $35,284 | $19,466 |
| 2021 | 7 | 239 | 856 | $174,582 | $40,171 |
| 2020 | 7 | 243 | 776 | $159,797 | $32,289 |
All Medicare Procedures & Services
23 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 64 | 96 | $9,888 | $6,069 | 61.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 59 | 82 | $12,792 | $5,355 | 41.9% |
| 72156 | Mri scan of upper spinal canal before and after contrast | Office | 2023 | 16 | 16 | $22,656 | $3,873 | 17.1% |
| 70553 | Mri scan of brain before and after contrast | Office | 2023 | 16 | 17 | $24,072 | $2,677 | 11.1% |
| 70551 | Mri scan of brain without contrast | Office | 2023 | 17 | 17 | $17,850 | $2,467 | 13.8% |
| 72141 | Mri scan of upper spinal canal without contrast | Office | 2023 | 16 | 16 | $16,800 | $1,522 | 9.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 88 | 192 | $29,952 | $16,394 | 54.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 13 | 13 | $2,860 | $1,663 | 58.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 17 | 24 | $2,472 | $1,409 | 57.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 94 | 204 | $31,824 | $17,319 | 54.4% |
| 72156 | Mri scan of upper spinal canal before and after contrast | Office | 2021 | 31 | 33 | $46,728 | $8,852 | 18.9% |
| 70553 | Mri scan of brain before and after contrast | Office | 2021 | 33 | 35 | $49,560 | $6,130 | 12.4% |
| 70551 | Mri scan brain | Office | 2021 | 20 | 21 | $22,050 | $3,525 | 16.0% |
| 72141 | Mri scan of upper spinal canal | Office | 2021 | 17 | 18 | $18,900 | $2,116 | 11.2% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 13 | 13 | $2,860 | $1,581 | 55.3% |
| A9579 | Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml | Office | 2021 | 31 | 532 | $2,660 | $647.24 | 24.3% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 103 | 186 | $29,016 | $13,019 | 44.9% |
| 72156 | Mri scan of upper spinal canal before and after contrast | Office | 2020 | 33 | 33 | $46,728 | $8,671 | 18.6% |
| 70553 | Mri scan of brain before and after contrast | Office | 2020 | 33 | 33 | $46,728 | $5,394 | 11.5% |
| 70551 | Mri scan brain | Office | 2020 | 17 | 17 | $17,850 | $2,526 | 14.2% |
| 72141 | Mri scan of upper spinal canal | Office | 2020 | 15 | 15 | $15,750 | $1,576 | 10.0% |
| A9579 | Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml | Office | 2020 | 31 | 481 | $2,405 | $577.73 | 24.0% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 11 | 11 | $1,320 | $524.79 | 39.8% |
About Peter Kinkel
Peter Kinkel is a Neurological Surgery healthcare provider based in Williamsville, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/10/2006. The National Provider Identifier (NPI) number assigned to this provider is 1831152701.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Peter Kinkel has received a total of $122,929 in payments from pharmaceutical and medical device companies, with $2,332 received in 2023. These payments were reported across 864 transactions from 36 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($88,414).
As a Medicare-enrolled provider, Kinkel has provided services to 788 Medicare beneficiaries, totaling 2,105 services with total Medicare billing of $113,889. Data is available for 4 years (2020–2023), covering 23 distinct procedure/service records.
Practice Information
- Specialty Neurological Surgery
- Location Williamsville, NY
- Active Since 04/10/2006
- Last Updated 10/24/2012
- Taxonomy Code 207T00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1831152701
Products in Payments
- GILENYA (Drug) $74,640
- OCREVUS (Biological) $17,886
- ACTHAR (Biological) $14,003
- AJOVY (Biological) $1,255
- KESIMPTA (Drug) $1,096
- AJOVY (Drug) $721.78
- AUSTEDO (Drug) $709.22
- COPAXONE (Drug) $696.14
- AUBAGIO (Drug) $509.24
- MAYZENT (Drug) $379.10
- RYTARY (Drug) $376.30
- AIMOVIG (Biological) $363.57
- MAVENCLAD (Drug) $324.18
- TYSABRI (Biological) $323.06
- UBRELVY (Drug) $235.87
- VALTOCO (Drug) $229.41
- Austedo XR (Drug) $198.30
- NUPLAZID (Drug) $196.31
- Rebif (Biological) $170.11
- GOCOVRI (Drug) $137.14
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurological Surgery Doctors in Williamsville
Dr. Adnan Siddiqui, Md, Phd, MD, PHD
Neurological Surgery — Payments: $2.0M
John Pollina, Md, MD
Neurological Surgery — Payments: $611,178
Dr. Elad Levy, Md, MD
Neurological Surgery — Payments: $350,993
Dr. Jeffrey Mullin, M.d, M.D
Neurological Surgery — Payments: $190,752
Douglas Moreland, Md, MD
Neurological Surgery — Payments: $45,766
Dr. Michael Landi, Md, MD
Neurological Surgery — Payments: $5,465